This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (107)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Review  • Alert me on articles by topic

B. de Valk, MD; J. J. M. Marx, MD, PhD

Arch Intern Med. 1999;159:1542-1548.

Objective  To review the epidemiological and experimental data concerning iron and the development of atherosclerosis and ischemic heart disease.

Data Sources  The English-language literature was searched from 1981 through 1998 manually and using MEDLINE and Current Contents. Important references in the articles that were found were also included in this review.

Results  There is growing epidemiological evidence for a relationship between iron levels and cardiovascular disease. Some experimental data support the role of iron in the process of lipid peroxidation, the first step in the formation of atherosclerotic lesions. Macrophages and endothelial cells are involved in this process, but the exact mechanism and the sites of the interactions between these cells, iron, and low-density lipoprotein are still unknown.

Conclusions  Strong epidemiological evidence is available that iron is an important factor in the process of atherosclerosis. Epidemiological studies, eg, prospective follow-up studies in blood donors, may clarify the cardiovascular benefits of iron depletion. Knowledge of the molecular mechanism of iron-related cardiovascular disease is still limited. We speculate that catalytically active iron species modify low-density lipoprotein levels to interact with the macrophage oxidized low-density lipoprotein receptor. Both nontransferrin-bound plasma iron and hemoglobin are candidates for such interactions.

From the Department of Internal Medicine and Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, University Hospital Utrecht, Utrecht, the Netherlands.

RELATED LETTER

Iron and Ischemic Heart Disease in the African Setting
Alexander R. P. Walker, Betty F. Walker, J. J. M. Marx, and B. de Valk
Arch Intern Med. 2000;160(2):241.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(14):1630-1631.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Accumulation of Zinc in Human Atherosclerotic Lesions Correlates With Calcium Levels But Does Not Protect Against Protein Oxidation
Stadler et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1024-1030.
ABSTRACT | FULL TEXT  

Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors
Edgren et al.
JNCI J Natl Cancer Inst 2008;100:572-579.
ABSTRACT | FULL TEXT  

Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice: A NOVEL BIOMARKER OF ATHEROSCLEROSIS
Watanabe et al.
J. Biol. Chem. 2007;282:23698-23707.
ABSTRACT | FULL TEXT  

The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation
Merle et al.
Endocrinology 2007;148:2663-2668.
ABSTRACT | FULL TEXT  

Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro
Carlini et al.
Nephrol Dial Transplant 2006;21:3055-3061.
ABSTRACT | FULL TEXT  

Iron Deficiency in the Acute-Phase Reaction After Open Aortic Surgery
Solis et al.
VASC ENDOVASCULAR SURG 2006;40:392-398.
ABSTRACT  

Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Swinkels et al.
Clin. Chem. 2006;52:950-968.
ABSTRACT | FULL TEXT  

Iron Chelation and Vascular Function: In Search of the Mechanisms
Ferrara and Taylor
Arterioscler. Thromb. Vasc. Bio. 2005;25:2235-2237.
FULL TEXT  

Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study
Ellervik et al.
Circulation 2005;112:185-193.
ABSTRACT | FULL TEXT  

Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study
Lee et al.
Am. J. Clin. Nutr. 2005;81:787-791.
ABSTRACT | FULL TEXT  

Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
Chait et al.
J. Lipid Res. 2005;46:389-403.
ABSTRACT | FULL TEXT  

Dietary haem iron and coronary heart disease in women
van der A et al.
Eur Heart J 2005;26:257-262.
ABSTRACT | FULL TEXT  

Serum ferritin levels are increased in patients with glomerular diseases and proteinuria
Branten et al.
Nephrol Dial Transplant 2004;19:2754-2760.
ABSTRACT | FULL TEXT  

Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes
Chicharro et al.
Br. J. Sports. Med. 2004;38:418-421.
ABSTRACT | FULL TEXT  

Heterozygosity for the haemochromatosis mutation HFE C282Y is not a risk factor for angina
Feeney et al.
Heart 2004;90:939-940.
FULL TEXT  

New and Emerging Theories of Cardiovascular Disease: Response to Commentaries
Alpert
Biol Res Nurs 2004;6:21-23.
 

Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper
Stadler et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:949-954.
ABSTRACT | FULL TEXT  

Regulated secretion of glycosylated human ferritin from hepatocytes
Ghosh et al.
Blood 2004;103:2369-2376.
ABSTRACT | FULL TEXT  

Body iron stores and their determinants in healthy postmenopausal US women
Liu et al.
Am. J. Clin. Nutr. 2003;78:1160-1167.
ABSTRACT | FULL TEXT  

Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Ramakrishna et al.
Vasc Med 2003;8:203-210.
ABSTRACT  

Serum Ferritin and Cardiovascular Disease: A 17-Year Follow-up Study in Busselton, Western Australia
Knuiman et al.
Am J Epidemiol 2003;158:144-149.
ABSTRACT | FULL TEXT  

Re: Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
Sullivan
JNCI J Natl Cancer Inst 2003;95:829-830.
FULL TEXT  

Regulation of xanthine oxidoreductase by intracellular iron
Martelin et al.
Am. J. Physiol. Cell Physiol. 2002;283:C1722-C1728.
ABSTRACT | FULL TEXT  

Iron Overload Augments Angiotensin II-Induced Cardiac Fibrosis and Promotes Neointima Formation
Ishizaka et al.
Circulation 2002;106:1840-1846.
ABSTRACT | FULL TEXT  

Do body iron stores increase the risk of developing coronary heart disease?
Sempos
Am. J. Clin. Nutr. 2002;76:501-503.
FULL TEXT  

Cross-Talk Between Iron Metabolism and Diabetes
Fernandez-Real et al.
Diabetes 2002;51:2348-2354.
ABSTRACT | FULL TEXT  

High Dietary Iron Concentrations Enhance the Formation of Cholesterol Oxidation Products in the Liver of Adult Rats Fed Salmon Oil with Minimal Effects on Antioxidant Status
Brandsch et al.
J. Nutr. 2002;132:2263-2269.
ABSTRACT | FULL TEXT  

Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study
Sarnak et al.
J Am Coll Cardiol 2002;40:27-33.
ABSTRACT | FULL TEXT  

High dose intravenous iron: a note of caution
Kletzmayr et al.
Nephrol Dial Transplant 2002;17:962-965.
FULL TEXT  

Body Iron Stores and Coronary Heart Disease
Ma and Stampfer
Clin. Chem. 2002;48:601-603.
FULL TEXT  

Biochemical and Genetic Markers of Iron Status and the Risk of Coronary Artery Disease: An Angiography-based Study
Bozzini et al.
Clin. Chem. 2002;48:622-628.
ABSTRACT | FULL TEXT  

Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Duffy et al.
Circulation 2001;103:2799-2804.
ABSTRACT | FULL TEXT  

Blood Donations and Risk of Coronary Heart Disease in Men
Ascherio et al.
Circulation 2001;103:52-57.
ABSTRACT | FULL TEXT  

Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles
Sham et al.
Blood 2000;96:3707-3711.
ABSTRACT | FULL TEXT  

Correspondence: The iron hypothesis: claim vs. hypothesis
Sullivan
Vasc Med 2000;5:127-128.
 

Iron and Ischemic Heart Disease in the African Setting
Walker et al.
Arch Intern Med 2000;160:241-241.
FULL TEXT